Up to 50% of people with diabetes have some degree of peripheral neuropathy, putting them at increased risk of foot ulceration, and up to 15% of all foot ulcers result in an amputation. This article describes a prevalence and incidence-based cost-of-illness study undertaken to qualify the annual cost to the NHS of diabetic peripheral neuropathy among people with type 1 and type 2 diabetes in the UK. The robustness of the cost estimates was assessed by performing sensitivity alyses in which the rates of complications were varied.
Unless otherwise indicated, works by Griffith University Scholars are © Griffith University. For further details please refer to the University Intellectual Property Policy.